Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Andong National University Industry-Academic Cooperation Foundation has 5 pending office actions in Biotechnology & Pharmaceuticals. These are handled by 5 distinct examiners across 3 distinct art units. BLUMEL, BENJAMIN P is the busiest examiner, managing 1 pending office action. The data shows that while examiners are unique for each of the 5 pending office actions, they are grouped within a smaller number of 3 distinct art units. This indicates some technical overlap in the pending matters.
The 5 pending office actions are distributed such that no single examiner, including BLUMEL, BENJAMIN P, handles more than 1 pending office action. This lack of examiner concentration means that prosecution outcomes will be determined by 5 different individuals. However, the concentration in 3 distinct art units suggests that the company's research is focused on a few specific areas within Biotechnology & Pharmaceuticals. Practitioners should analyze the tendencies of these 3 distinct art units to effectively manage the 5 pending office actions and ensure consistent prosecution across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| §103 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
| GONZALEZ, LUISALBERTO | 1 | 59.7% | +46.3% |
| MOREAU, NASHARA LOUISE | 1 | 66.7% | -80.0% |
| CHEN, CATHERYNE | 1 | 37.5% | +17.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 50d |
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — |
| 18594709 | ANTI-OBESITY COMPOSITION CONTAINING HEMP SEED EXTRACT AS ACTIVE INGREDIENT | SPAINE, ROBERT FRANKLIN | — |
| 18588681 | CONTACT PHEROMONE-CONTAINING COMPOSITION FOR CONTROLLING THRIPS, KIT COMPOSITION FOR CONTROLLING THRIPS, AND METHOD OF CONTROLLING THRIPS BY USING SAME | GONZALEZ, LUISALBERTO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 50d |
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | — |
| 18588681 | CONTACT PHEROMONE-CONTAINING COMPOSITION FOR CONTROLLING THRIPS, KIT COMPOSITION FOR CONTROLLING THRIPS, AND METHOD OF CONTROLLING THRIPS BY USING SAME | GONZALEZ, LUISALBERTO | — |
| Art Unit | Apps |
|---|---|
| 1655 | 3 |
| 1671 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18611577 | DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS | BLUMEL, BENJAMIN P | 1671 | §101§102§103§112 | Final Rejection | — | Pending | Mar 20, 2024 |
| 18594709 | ANTI-OBESITY COMPOSITION CONTAINING HEMP SEED EXTRACT AS ACTIVE INGREDIENT | SPAINE, ROBERT FRANKLIN | 1655 | §103§112Other | Final Rejection | — | Pending | Mar 04, 2024 |
| 18588681 | CONTACT PHEROMONE-CONTAINING COMPOSITION FOR CONTROLLING THRIPS, KIT COMPOSITION FOR CONTROLLING THRIPS, AND METHOD OF CONTROLLING THRIPS BY USING SAME | GONZALEZ, LUISALBERTO | 1624 | §103§112 | Final Rejection | — | Pending | Feb 27, 2024 |
| 18544358 | COMPOSITION INCLUDING PROPOLIS AND SORBUS COMMIXTA AS ACTIVE INGREDIENTS FOR ALLEVIATING AND TREATING INFLAMMATORY DISEASES AND ALLERGIC DISEASES | MOREAU, NASHARA LOUISE | 1655 | §103 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 1655 | §101§102§103 | Final Rejection | 50d | Pending | Feb 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAndong National University Industry-Academic Cooperation Foundation has 5 pending office actions as of October 2026, spread across 3 art units and 5 examiners.
Benjamin P Blumel has the most, with 1 of Andong National University Industry-Academic Cooperation Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
